S. Lee

Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density.

S. Lee, D Y Chen, Jeffrey S. Humphrey et al. · Proceedings of the National Academy of Sciences · 1996 · 157 citations

Life Sciences, Molecular Biology, Oncology +17

Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.

Delin Duan, Jeffrey S. Humphrey, D Y Chen et al. · Proceedings of the National Academy of Sciences · 1995 · 157 citations

Medicine, Genetics, Molecular Biology +16

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer

C.A. Carter, Arun Rajan, Corrine Keen et al. · Annals of Oncology · 2016 · 90 citations

Medicine, Oncology, Pharmacology +17

Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer

Austin G. Duffy, Oxana V. Makarova‐Rusher, Susanna V. Ulahannan et al. · International Journal of Cancer · 2016 · 75 citations · Full text

Medicine, Oncology, Pharmacology +15